当前位置: X-MOL 学术JACC Cardiovasc. Inte. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction
JACC: Cardiovascular Interventions ( IF 11.3 ) Pub Date : 2021-10-27 , DOI: 10.1016/j.jcin.2021.08.021
Ik Jun Choi 1 , Sungmin Lim 2 , Eun Ho Choo 3 , Byung-Hee Hwang 3 , Chan Joon Kim 4 , Mahn-Won Park 5 , Jong-Min Lee 4 , Chul Soo Park 6 , Hee Yeol Kim 7 , Ki-Dong Yoo 8 , Doo Soo Jeon 9 , Ho Joong Youn 3 , Wook-Sung Chung 3 , Min Chul Kim 10 , Myung Ho Jeong 10 , Youngkeun Ahn 10 , Kiyuk Chang 11
Affiliation  

Objectives

The aim of this study was to examine the impact of intravascular ultrasound (IVUS)–guided percutaneous coronary intervention (PCI) on long-term clinical outcomes in patients with acute myocardial infarction (AMI).

Background

IVUS-guided PCI has been associated with improved cardiovascular outcomes. However, the beneficial effect of IVUS-guided PCI in patients with AMI in the drug-eluting stent era remains unclear.

Methods

Patients who underwent PCI with drug-eluting stents were selected from 10,719 patients enrolled in a multicenter AMI registry. The included patients were classified into 2 groups according to the use or nonuse of IVUS. The primary outcome was a composite of major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, and target lesion revascularization, during long-term follow-up.

Results

A total of 9,846 patients were treated with IVUS-guided PCI (n = 2,032) or angiography-guided PCI (n = 7,814). IVUS-guided PCI was associated with reduced MACE (HR: 0.779; 95% CI: 0.689-0.880; P < 0.001). The results were consistent after multivariable regression and propensity score matching. One-year landmark analysis showed a lower risk for MACE within 1 year (HR: 0.766; 95% CI: 0650-0.903; P = 0.002) and beyond 1 year (HR: 0.796; 95% CI: 0663-0.956; P = 0.014) after index PCI.

Conclusions

The use of IVUS was associated with better long-term cardiovascular outcomes. The clinical benefit of IVUS was maintained both within and beyond 1 year after index PCI. The use of IVUS in PCI should be considered for patients with AMI.



中文翻译:

血管内超声对急性心肌梗死患者长期临床结局的影响

目标

本研究旨在探讨血管内超声 (IVUS) 引导下的经皮冠状动脉介入治疗 (PCI) 对急性心肌梗死 (AMI) 患者长期临床结局的影响。

背景

IVUS 引导的 PCI 与改善心血管结局相关。然而,在药物洗脱支架时代,IVUS 引导的 PCI 对 AMI 患者的有益效果仍不清楚。

方法

接受药物洗脱支架 PCI 的患者选自多中心 AMI 登记的 10,719 名患者。根据是否使用IVUS将纳入的患者分为2组。主要结局是长期随访期间主要不良心血管事件 (MACE) 的复合结果,包括心血管死亡、心肌梗死和靶病变血运重建。

结果

共有 9,846 名患者接受了 IVUS 引导的 PCI (n = 2,032) 或血管造影引导的 PCI (n = 7,814) 的治疗。IVUS 引导的 PCI 与 MACE 减少相关(HR:0.779;95% CI:0.689-0.880;P  < 0.001)。多变量回归和倾向评分匹配后的结果是一致的。一年里程碑分析显示,1 年内(HR:0.766;95% CI:0650-0.903;P  = 0.002)和 1 年后(HR:0.796;95% CI:0663-0.956;P  = 0.014) 在指数 PCI 之后。

结论

IVUS 的使用与更好的长期心血管结局相关。IVUS 的临床获益在指数 PCI 后 1 年内和 1 年后均保持不变。AMI 患者应考虑在 PCI 中使用 IVUS。

更新日期:2021-11-16
down
wechat
bug